CTNNB1 and neoplasm: We observed one tumour (PR0139) with three distinct CTNNB1 mutations, all previously described gain-of-function mutations in exon 3 of CTNNB1 leading to stabilisation of β-catenin and activation of Wnt/β-catenin signalling (Figure 4A).